Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03628716
Title CV301 Combined With PD-1/L1 Blockade in Patients With Locally Advanced or Metastatic Urothelial Bladder Cancer
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Bavarian Nordic
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.